BioRestorative surges ~30% on upcoming US patent linked to metabolic ThermoStem program

Mar. 02, 2023 8:18 AM ETBioRestorative Therapies, Inc. (BRTX)By: Ravikash, SA News Editor

Magnifier focuses on the word patent. Concept of patenting or copyright protection

cagkansayin

  • BioRestorative Therapies (NASDAQ:BRTX) said the U.S. Patent and Trademark Office (USPTO) issued a notice of allowance for a patent application related to its metabolic ThermoStem program.
  • The upcoming patent would be the third U.S. patent to issue from the company's ThermoStem family aimed at obesity and metabolic disorders, including type 2 diabetes, BioRestorative added.
  • The company noted that claims granted under the new patent cover implantable three-dimensional scaffolds and brown adipocytes which have been derived from human brown adipose-derived stem cells.
  • "Additionally, it enhances our ability to engage with the strategic community on collaborative and partnering opportunities," said CEO Lance Alstodt.
  • BRTX +32.26% to $3.69 premarket March 2

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.